29
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cytotoxic Immunity in Peripheral Nerve Injury and Pain

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cytotoxicity and consequent cell death pathways are a critical component of the immune response to infection, disease or injury. While numerous examples of inflammation causing neuronal sensitization and pain have been described, there is a growing appreciation of the role of cytotoxic immunity in response to painful nerve injury. In this review we highlight the functions of cytotoxic immune effector cells, focusing in particular on natural killer (NK) cells, and describe the consequent action of these cells in the injured nerve as well as other chronic pain conditions and peripheral neuropathies. We describe how targeted delivery of cytotoxic factors via the immune synapse operates alongside Wallerian degeneration to allow local axon degeneration in the absence of cell death and is well-placed to support the restoration of homeostasis within the nerve. We also summarize the evidence for the expression of endogenous ligands and receptors on injured nerve targets and infiltrating immune cells that facilitate direct neuro-immune interactions, as well as modulation of the surrounding immune milieu. A number of chronic pain and peripheral neuropathies appear comorbid with a loss of function of cellular cytotoxicity suggesting such mechanisms may actually help to resolve neuropathic pain. Thus while the immune response to peripheral nerve injury is a major driver of maladaptive pain, it is simultaneously capable of directing resolution of injury in part through the pathways of cellular cytotoxicity. Our growing knowledge in tuning immune function away from inflammation toward recovery from nerve injury therefore holds promise for interventions aimed at preventing the transition from acute to chronic pain.

          Related collections

          Most cited references245

          • Record: found
          • Abstract: found
          • Article: not found

          A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man

          A peripheral mononeuropathy was produced in adult rats by placing loosely constrictive ligatures around the common sciatic nerve. The postoperative behavior of these rats indicated that hyperalgesia, allodynia and, possibly, spontaneous pain (or dysesthesia) were produced. Hyperalgesic responses to noxious radiant heat were evident on the second postoperative day and lasted for over 2 months. Hyperalgesic responses to chemogenic pain were also present. The presence of allodynia was inferred from the nocifensive responses evoked by standing on an innocuous, chilled metal floor or by innocuous mechanical stimulation, and by the rats' persistence in holding the hind paw in a guarded position. The presence of spontaneous pain was suggested by a suppression of appetite and by the frequent occurrence of apparently spontaneous nocifensive responses. The affected hind paw was abnormally warm or cool in about one-third of the rats. About one-half of the rats developed grossly overgrown claws on the affected side. Experiments with this animal model may advance our understanding of the neural mechanisms of neuropathic pain disorders in humans.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Different immune cells mediate mechanical pain hypersensitivity in male and female mice.

            A large and rapidly increasing body of evidence indicates that microglia-to-neuron signaling is essential for chronic pain hypersensitivity. Using multiple approaches, we found that microglia are not required for mechanical pain hypersensitivity in female mice; female mice achieved similar levels of pain hypersensitivity using adaptive immune cells, likely T lymphocytes. This sexual dimorphism suggests that male mice cannot be used as proxies for females in pain research.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Natural killer cells and other innate lymphoid cells in cancer

              Immuno-oncology is an emerging field that has revolutionized cancer treatment. Most immunomodulatory strategies focus on enhancing T cell responses, but there has been a recent surge of interest in harnessing the relatively underexplored natural killer (NK) cell compartment for therapeutic interventions. NK cells show cytotoxic activity against diverse tumour cell types, and some of the clinical approaches originally developed to increase T cell cytotoxicity may also activate NK cells. Moreover, increasing numbers of studies have identified novel methods for increasing NK cell antitumour immunity and expanding NK cell populations ex vivo, thereby paving the way for a new generation of anticancer immunotherapies. The role of other innate lymphoid cells (group 1 innate lymphoid cell (ILC1), ILC2 and ILC3 subsets) in tumours is also being actively explored. This Review provides an overview of the field and summarizes current immunotherapeutic approaches for solid tumours and haematological malignancies.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Neurosci
                Front Neurosci
                Front. Neurosci.
                Frontiers in Neuroscience
                Frontiers Media S.A.
                1662-4548
                1662-453X
                21 February 2020
                2020
                : 14
                : 142
                Affiliations
                [1] 1Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford , Oxford, United Kingdom
                [2] 2Department of Anesthesia, Boston Children’s Hospital, Harvard Medical School , Boston, MA, United States
                [3] 3Department of Neurobiology, Boston Children’s Hospital, Harvard Medical School , Boston, MA, United States
                [4] 4Department of Brain and Cognitive Sciences, College of Natural Sciences, Seoul National University , Seoul, South Korea
                [5] 5Dental Research Institute and Department of Neurobiology & Physiology, School of Dentistry, Seoul National University , Seoul, South Korea
                Author notes

                Edited by: Nick Andrews, Harvard Medical School, United States

                Reviewed by: Dara Bree, Cygnal Therapeutics, United States; Halina Machelska, Charité – Medical University of Berlin, Germany

                *Correspondence: Alexander J. Davies, alexander.davies@ 123456ndcn.ox.ac.uk

                This article was submitted to Neuropharmacology, a section of the journal Frontiers in Neuroscience

                Article
                10.3389/fnins.2020.00142
                7047751
                32153361
                e9a932a8-4790-4040-85b0-3786adca8d71
                Copyright © 2020 Davies, Rinaldi, Costigan and Oh.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 31 December 2019
                : 04 February 2020
                Page count
                Figures: 3, Tables: 0, Equations: 0, References: 301, Pages: 20, Words: 0
                Funding
                Funded by: Medical Research Council 10.13039/501100000265
                Award ID: MR/POO8399/1
                Funded by: National Institute for Health Research 10.13039/501100000272
                Funded by: National Research Foundation of Korea 10.13039/501100003725
                Award ID: 2018R1A5A2024418
                Categories
                Neuroscience
                Review

                Neurosciences
                neuropathic pain,peripheral neuropathy,nerve injury,cellular cytotoxicity,innate immunity,natural killer cells,neuro-immunology,neuron-glia crosstalk

                Comments

                Comment on this article